Who Paid My Doc
Research studies in the Open Payments record
139,921 studies have research funding reported against them. Being named on a study as a principal investigator is reported separately from being paid.
Studies
50 of 139,921- M16-142 NCT03859869
- M16-183 NCT03484520
- M16-185 NCT03557619
- M16-186 NCT03441555
- M16-191 NCT04472598
- M16-191 - Study of Oral Navitoclax Tablet In Combination With Oral Ruxolitinib Tablet When Compared With Oral Ruxolitinib Tablet To Assess Change In Spleen Volume In Adult Participants With Myelofibrosis No ClinicalTrials.gov identifier reported
- M16-194 - A Study to Assess Adverse Events Change in Disease Activity and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn s Disease No ClinicalTrials.gov identifier reported
- M16-194 Skyrizi Ph3 PIP CD NCT05995353
- M16-244 NCT02986373
- M16-283 NCT03271489
- M16-283 NCT02925494
- M16-283 NCT02755597
- M16-283 - Long-Term Safety Study of Elagolix in Combination With Estradiol Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women No ClinicalTrials.gov identifier reported
- M16-289 NCT03061812
- M16-290 NCT000000NA
- M16-291 NCT03543358
- M16-292 NCT03334487
- M16-294 NCT000000NA
- M16-296 NCT000000NA
- M16-298 NCT03033511
- M16-300 NCT03026166
- M16-306 No ClinicalTrials.gov identifier reported
- M16-310 NCT03253185
- M16-312 NCT03035279
- M16-383 NCT03343067
- M16-415 NCT03360006
- M16-438 NCT03234712
- M16-534 NCT03419403
- M16-553 NCT03138408
- M16-560 NCT03823391
- M16-573 NCT03595059
- M16-641 NCT000000NA
- M16-641 NCT03695185
- M16-735 NCT03316794
- M16-766 NCT03478787
- M16-785 NCT03797261
- M16-788 NCT03406156
- M16-802 NCT03625505
- M16-813 NCT03706040
- M16-824 NCT03886220
- M16-833 NCT03926169
- M16-837 NCT03951077
- M16-852 NCT03725202
- M16-852 - A Study to Evaluate the Safety and Efficacy of Upadacitinib in Participants With Giant Cell Arteritis No ClinicalTrials.gov identifier reported
- M16-856 NCT000000NA
- M16-904 NCT03695237
- M16-904 - A Study to Evaluate Safety Efficacy Pharmacokinetics and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Formulation in Children With Central Precocious Puberty (CPP) No ClinicalTrials.gov identifier reported
- M16-948 NCT03413319
- M17-220 No ClinicalTrials.gov identifier reported
- M17-220 NCT000000NA